NPRA mission is to safeguard the nation’s health through scientific excellence in the regulatory control of medicinal products and cosmetics.
COVID-19
PRODUCT SEARCH
REPORTING OF SIDE EFFECTS TO MEDICINES OR VACCINES
Direktif untuk penggunaan Drug Registration Guidance Document (DRGD) Third Edition, Eighth Revision July 2024 |
17-Hydroxyprogesterone Caproate (17-OHPC): Potential Cancer Risk in Offspring Exposed in Utero and Limited Efficacy Data |
Pre-Membership Module Announcement |
List of Renewal Approved Veterinary Products |
Hydroxychloroquine: Risk of Sweet’s Syndrome (Acute Febrile Neutrophilic Dermatosis) |
15 Oct 2024; 08:00AM - 05:00PM MOPI Training 2024: A practical approach to ISO 13485 QMS for medical devices |
25 Sep 2024; 08:00AM - 05:00PM MOPI Training 2024: Contamination Control - How to Develop an Effective Contamination Control Strategy |
10 Sep 2024; 08:00AM - 05:00PM MOPI Training 2024: Supply chain management and Supplier QA program-Application of QRM principles |
27 Aug 2024; 08:00AM - 05:00PM MOPI Training 2024: Internal Audit – a key to effective Quality System |
13 Aug 2024; 08:00AM - 05:00PM MOPI Training 2024: Cleaning Validation |